Aura Biosciences Ownership | Who Owns Aura Biosciences?
Aura Biosciences Ownership Summary
Aura Biosciences is owned by 74.23% institutional investors, 5.08% insiders, and 20.69% retail investors. Matrix capital management company, lp is the largest institutional shareholder, holding 14.00% of AURA shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 11.70% of its assets in Aura Biosciences shares.
AURA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Aura Biosciences | 74.23% | 5.08% | 20.69% |
Sector | Healthcare Stocks | 49.65% | 8.78% | 41.57% |
Industry | Biotech Stocks | 46.85% | 8.74% | 44.40% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Matrix capital management company, lp | 6.92M | 14.00% | $52.34M |
Eventide asset management | 5.80M | 11.73% | $43.87M |
Adage capital partners gp | 4.88M | 9.88% | $36.93M |
Medicxi ventures management (jersey) | 3.04M | 6.15% | $22.98M |
Blackrock | 3.01M | 6.08% | $22.72M |
Vanguard group | 1.77M | 3.57% | $13.36M |
Franklin resources | 1.45M | 2.94% | $10.99M |
Nantahala capital management | 1.27M | 2.57% | $9.60M |
Long focus capital management | 1.06M | 2.14% | $7.99M |
Goldman sachs group | 1.03M | 2.08% | $7.79M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Medicxi ventures management (jersey) | 3.04M | 6.85% | $22.98M |
Regency capital management inc.\de | 765.05K | 3.72% | $5.78M |
Decheng capital | 515.55K | 1.19% | $3.90M |
Eventide asset management | 5.80M | 0.75% | $43.87M |
Nantahala capital management | 1.27M | 0.56% | $9.60M |
Matrix capital management company, lp | 6.92M | 0.40% | $52.34M |
Long focus capital management | 1.06M | 0.31% | $7.99M |
Adar1 capital management | 203.24K | 0.29% | $1.54M |
Levin capital strategies | 327.47K | 0.26% | $2.48M |
Tbh global asset management | 60.32K | 0.10% | $456.04K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Long focus capital management | 1.06M | 0.31% | 561.77K |
Blackrock | 3.01M | 0.00% | 560.52K |
Adage capital partners gp | 4.88M | 0.07% | 420.00K |
Levin capital strategies | 327.47K | 0.26% | 216.27K |
Adar1 capital management | 203.24K | 0.29% | 203.24K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Jefferies financial group | - | - | -222.50K |
Verition fund management | - | - | -151.68K |
Ensign peak advisors | 251.91K | 0.00% | -105.32K |
Fmr | 230.45K | 0.00% | -64.20K |
Nantahala capital management | 1.27M | 0.56% | -51.83K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Adar1 capital management | 203.24K | 0.29% | 203.24K | $1.54M |
Corton capital | 25.18K | 0.10% | 25.18K | $190.39K |
Commonwealth equity services | 25.00K | 0.00% | 25.00K | $189.00K |
Corebridge financial | 24.95K | 0.00% | 24.95K | $188.64K |
Mirae asset global etfs | 17.90K | 0.00% | 17.90K | $135.30K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -4.00 |
Metropolitan life insurance co/ny | -1.55K |
Entrypoint capital | -3.57K |
Squarepoint ops | -10.45K |
Xtx topco | -11.59K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 86 | 13.16% | 36,866,668 | -6.95% | 74 | 1.16% | 41 | -8.89% | 25 | 25.00% |
Jun 30, 2024 | 76 | -3.80% | 39,620,998 | 1.29% | 80 | 0.82% | 45 | -2.17% | 20 | 11.11% |
Mar 31, 2024 | 79 | 8.22% | 39,115,323 | 5.72% | 98 | 1.05% | 46 | -9.80% | 18 | 63.64% |
Dec 31, 2023 | 73 | 12.31% | 36,998,812 | 34.61% | 96 | 1.84% | 51 | 59.38% | 11 | -42.11% |
Sep 30, 2023 | 65 | 6.56% | 27,486,233 | 1.55% | 72 | 1.42% | 32 | -17.95% | 19 | 58.33% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Eventide Healthcare & Life Sciences I | 5.80M | 11.70% | - |
iShares Russell 2000 ETF | 1.13M | 2.28% | -2.55K |
Franklin Biotechnology Discv A(acc)USD | 1.10M | 2.21% | 13.16K |
Vanguard Total Stock Mkt Idx Inv | 1.02M | 2.05% | 171.00K |
Vanguard Institutional Extnd Mkt Idx Tr | 633.97K | 1.27% | - |
Franklin Biotechnology Discovery A | 594.11K | 1.20% | 25.64K |
Fidelity Small Cap Index | 473.96K | 0.96% | -12.24K |
iShares Russell 2000 Value ETF | 434.99K | 0.88% | - |
T. Rowe Price Health Sciences | 347.02K | 0.70% | -6.92K |
Fidelity Extended Market Index | 225.35K | 0.45% | 1.76K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 18, 2024 | Hopkins Janet Jill | Chief Medical Officer | Sell | $110.66K |
Oct 29, 2024 | de los Pinos Elisabet | See Remarks | Sell | $98.79K |
Oct 29, 2024 | Elazzouzi Amy | Vice President, Finance | Sell | $5.94K |
Oct 18, 2024 | Feder Julie B | Chief Financial Officer | Sell | $302.36K |
Oct 18, 2024 | de los Pinos Elisabet | See Remarks | Sell | $300.84K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 6 |
2024 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | - | 2 |
2023 Q4 | 7 | 4 |
AURA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools